
Regulatory review: USFDA’s gummy study, Australia’s rules on andrographis and more
The U.S. Food and Drug Administration’s (USFDA) assessment of gummy supplements production, Australia’s stricter rules on andrographis use and New Zealand’s upcoming revisions to its natural health products export policies are some of the latest updates...















































